The Korean biotechnology company CG Bio is a comprehensive healthcare provider, aiming to improve quality of life through a range of innovative solutions for the treatment of spinal disorders and wound management.

With extensive research activities, state-of-the-art facilities, and high-standard equipment, the company is at the forefront of regenerative medicine worldwide, based on biomaterial technology, while specializing in collagen-hydroxyapatite biostimulants.